The ASHP Foundation Pharmacy Forecast has been a valuable source of insight and guidance about our profession as it is influenced by or influences external factors in our environment. ASHP and the ASHP Research and Education Foundation (“the Foundation”) present this ninth edition of the annual Pharmacy Forecast and are pleased to disseminate the Pharmacy Forecast through AJHP, providing readers with easy access to the report. The staff of AJHP has provided substantial editorial support for this publication, and we appreciate their assistance. The Pharmacy Forecast is a vital component of ASHP’s efforts to advance pharmacy practice leadership, and the Foundation appreciates the many pharmacists and others who have contributed to the David A. Zilz Leaders for the Future fund, which provides the resources to develop the report. The Foundation is also grateful to Omnicell for their support of the Zilz fund, which has made the Pharmacy Forecast possible. The Pharmacy Forecast could not be created without the contributions of the report’s founding editor, William Zellmer; members of the Forecast 2021 Advisory Committee; Forecast Panelists (FPs) who responded to the forecast survey; and chapter authors. ASHP and the Foundation are indebted to those individuals who have helped make the 2021 edition a success. Over the past 8 years, the Pharmacy Forecast has provided insight into emerging trends and phenomena that have impacted the practice of pharmacy and the health of patients in health systems. The value of the report is determined by its value to health-system pharmacists and health-system pharmacy leaders as they use the report to inform their strategic planning efforts. The Pharmacy Forecast is not intended to be an accurate prediction of future events. Rather, the report is intended to be a provocative stimulant for the thinking, discussion, and planning that must take place in every hospital and health system in order for those organizations to succeed in their mission of caring for patients and advancing the profession of pharmacy. Some may disagree with the opinions of the FPs or the positions taken by individual chapter authors with respect to their vision of the future. That is acceptable and desirable. Also, the report reflects a consensus of the national direction and may not reflect what is likely to occur in your geographic region or state. Reflect those differing opinions in your organization’s strategic planning process and chart a course for your organization that is consistent with your beliefs, and the Pharmacy Forecast will have met its objective of encouraging planning efforts of health systems. We welcome your comments on this new 2021 edition of the Pharmacy Forecast. Suggestions for future forecasts can be sent to any of the forecast editors through the Foundation’s Pharmacy Forecast website at http://www.ashpfoundation.org/pharmacyforecast and will be considered for future editions. Joseph T. DiPiro, PharmD, FCCP, FAAAS, Dean, School of Pharmacy, Virginia Commonwealth University, Richmond, VA Address correspondence to Dr. DiPiro (jtdipiro@vcu.edu). An underlying assumption supporting the need for the Pharmacy Forecast is that many factors influencing our profession and pharmacy services are not directly under our control, yet we can take actions that enhance the likelihood of favorable outcomes within this environment. Those influencing factors may be as a specific state or national policy or regulation, or as nebulous as the trend toward globalization (or anti-globalization). Other than the COVID-19 pandemic, the influencing factors such as the prominence of “big data,” issues of personal privacy, financing and health access are not new and have emerged over time. Within that context, then, we have greatest control over the scope of our pharmacy enterprise and the workforce within that enterprise, and some control over those factors where we can advocate to the decision makers (such as health-system administrators, legislators, and government agency officials). The perspective gained from reading the 2021 Pharmacy Forecast is most effectively used within the process of strategic planning as part of environmental scanning or when identifying strengths, weaknesses, opportunities, or threats (SWOT). In addition, the recommendations provided below can be part of the institution’s strategic planning action steps. The methods used to develop the 2021 Pharmacy Forecast were similar to those used in the previous editions, drawing on concepts described in James Surowiecki’s book The Wisdom of Crowds.1 According to Surowiecki, the collective opinions of “wise crowds”—groups of diverse individuals in which each participant’s input is provided independently, drawing from their own locally informed points of view—can be more informative than the opinion of any individual participant. This process is particularly valuable when addressing phenomena that are not well suited to quantitative predictive methods. A critical requirement for successfully creating crowd-based knowledge is establishing a systematic method of combining individual beliefs into a collective opinion—the Pharmacy Forecast uses a survey of carefully selected pharmacy leaders to derive our environmental scan. The 2021 Pharmacy Forecast Advisory Committee (see membership list in the Foreword) began the development of survey by of issues and they will health-system pharmacy in the That list and through an in a of each with on which the survey of survey to the selected and to and in the Pharmacy Forecast survey Forecast Panelists selected by ASHP staff by the leaders of the ASHP were to individuals to have in health-system pharmacy and knowledge of trends and new in the The of and within the Forecast were intended to opinions from a of pharmacy The Pharmacy Forecast survey FPs to each of the in survey and the likelihood of those in the were to their on their knowledge of in their not on their of national The carefully the of the to reflect a national were to a the likelihood of those or to This we to present in this of on Pharmacy Forecast in the of the the COVID-19 pandemic, and and within our William to reflect on the our national and it could to the of the COVID-19 on selected within the Pharmacy Forecast to the of and The of the of the method is on the of the to the forecast it is to the and of the A of FPs were to the forecast were from similar to the in previous of the FPs been in practice for than years, and been in practice for than FPs described their practice as a hospital or health of FPs were from or health systems. were from with the previous FPs that their organizations diverse health or pharmacy and of their organizations a pharmacy and provided of the FPs the of pharmacy of or of pharmacy and of of FPs their as or and as described their as of as their with the previous The of FPs leaders and at and with of FPs were by with or more and of were from of than the of the Forecast similar to that in previous in the of from each region from in and the to in the In the 2021 every region by a of Forecast by Forecast by of the report provides a of the survey and perspective of the chapter and strategic the individual survey on a specific of the the of in each chapter is and when The by and on the A assumption is that the at and the will likely such as the COVID-19 and in that could the or the of can and we within health to for access to has been an it has and as our with and access The of new provides to access to in scope of practice and for of pharmacy services to in pharmacy services and in have more and use of has more and the of use to develop more and consistent of and also the of in that have access to a of and a for past Forecast editions, is by and and a scope of from pharmacy to with and The of health is of in the chapter as for the requirement are under by and state is in the chapter by James and David and the from previous of Pharmacy Forecast. The authors the as an to the we about also the of the pharmacists as leaders and the of pharmacy and in staff and to We are that the scope of the pharmacy enterprise in health has and in the past and of access to pharmacists in as well as the for from also and likely in the and of pharmacy with in the pharmacy enterprise, have been and will to be in our pharmacy and issues are by and the issues that have been for are and also the to enhance through of and of the could be impacted by a in the of pharmacy the The of the Pharmacy Forecast is on trends that will over and and not on The 2021 edition of the Pharmacy Forecast from past by of the of that have from previous The report is intended to and discussion, providing a for individuals and who to and their and for future and trends than be to those that This is the most of for strategic the process of strategic planning pharmacy staff at the Pharmacy Forecast provides guidance to in health-system strategic planning and it is that the report be by the Pharmacy it is that at or past in to this new many of the and recommendations that are or to of the Pharmacy Forecast can be on the ASHP Foundation website at Those organizations in or the use of the Pharmacy Forecast as a and use the report as part of or to pharmacy in about the future of the profession they are to as the pharmacy workforce is to leadership, the Pharmacy Forecast many issues that are well the of pharmacy and the The of the report inform the scope of that many pharmacists The Pharmacy Forecast be with health-system leaders and as a to the pharmacy and to the emerging trends will many of health systems. Dr. DiPiro on the AJHP Advisory and of and of of Pharmacy, of on of and and Address correspondence to Dr. a and the and of the health-system pharmacists must be for to of are not new to in the and the has the of the The of and from in to in with many of the in by the of to Forecast Panelists (FPs) that at of health will develop through or similar to resources a In the of the pandemic, as were with of personal and the of that helped some and to the such as those at the and the are also guidance for Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where health substantial from and many FPs were that resources be made to for has been were provided to health with in more than in by assistance. A from a report by the and to develop a system to for to in their to more in to health that or to the leaders have been for such a system to the likelihood of and to The FPs were on the of the of with and of with and have in years, also to in the and such as to with more for and of and to to a method to the of not A the of the the of the were that to in or that some to for their A list of to to the of the source of and or of the FPs that issues such as or will the for to not to more patients with COVID-19 in the those were to an from than this to The Research and provided a to and the intended to to also to to the over a of FPs the will to from to The about on and by the most for in the are the most and of some have been to system and of access for of has been for were to for more of in the of by the of may not be may develop for to (or by the of of those of without in the made by of the and could or enhance your health for with health and and state to for or of resources such as to on when and that on of health also a of policy within your of at your health within state and national hospital and pharmacy to support that on and the of Dr. is an of the for and a of the AJHP Advisory The of has a to with The value of the than of the for also on the AJHP Advisory Dr. is by and the for FCCP, and of of Pharmacy, and of of of FCCP, and of Pharmacy and of of Pharmacy, of Pharmacy and of of Pharmacy, Address correspondence to Dr. to the health of those in of the the health of the COVID-19 and the of health in the it is to to of pharmacy and their in scope of of and access to than of Forecast Panelists (FPs) of access to in and use of to services and outcomes and in will and have the for this to In we have a in the COVID-19 pandemic, with such as are and for access to may be a in some and to be use of for services such as of and and recommendations will likely to to its and Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where of FPs that pharmacy will be with patients and in and to access An which pharmacy with patients to and access and outcomes and of of FPs it is not likely that pharmacy will take on this with pharmacy can successfully support is pharmacy leaders to the pharmacy can as their scope of practice may and to and the patients they of FPs of will have a through which scope of practice can be when health are as in the with of pharmacists to the in to the COVID-19 pandemic, the and pharmacists to order and COVID-19 and the of state to of by and by pharmacists more the of scope of and more health is a in the of FPs were on at of health will their with the of health and health that their region from to the as they to be the of a is with of national organization and to which more in and and many the of a or will to and likely not be in the future. The of FPs not that at of health will access to likely to and as to the of and of use is under and hospital through the for and health that access to at as use could in of or substantial at of in and have from use of of by is to by may be to in health systems. The in on with which hospital into the hospital by their or 8 into the health system pharmacy and of and into the and for In addition, began in the of of control and of for and in for the on the use of the to that will enhance the outcomes of patients in your health those in pharmacy in your pharmacy enterprise can be more and effectively by to enhance and with pharmacy leaders in your state the and of any pharmacy scope of practice that in to the or health with the pharmacy leaders of health in your region the for of and the a process within your health system of to use of The authors have of VA are and for a in pharmacy health have on health and which health and that the The has to place more on the of and this knowledge through the and of that an as a the likelihood that will be used for and decision Pharmacy as by the and on and knowledge within the of its use and the of and health and health are not from pharmacy and pharmacy they not a as some have In more be on pharmacy as the and use of from to practice outcomes and within pharmacy and use to support and individual and health and with for and health will be with use that will present and may be and for within the at the be and to use of to the and of for the of and the development of that of they are The of a in each health or with health is within systems. Forecast Panelists (FPs) a the likelihood of used for of this for a pandemic, or to may be more than FPs were on health will have that of with will be by and about by be they or of FPs that over the health the of and to are to in with the and or many health health as and may not to from their with pharmacists or of the health may be to for are many to and to outcomes and may be to and the for to in FPs that will be used to for patients for This may be on the knowledge that and health to of every Pharmacy guidance on to will be are through the use of and and of FPs will be used to and to to be this will be to or to of FPs it likely that within the will when a order from the institution’s of use recommendations over of will be to to and support decision and the of their use on Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where and a of with pharmacists to make for individual patients are to for or through that the and of and for and in the to and use that pharmacy with the health-system to and issues to patients and Pharmacy have the and to of and or issues in the process that development of an in and of that of hospital and for and outcomes the strategic direction of pharmacy and pharmacy as well as and use the of knowledge into pharmacy that and of to and health and enhance and health with the health and the of and individuals to their new pharmacy of that use guidance to in that and that outcomes and to the and of the institution’s develop and that and outcomes are for and Dr. on the AJHP Advisory Dr. has of Pharmacy Address correspondence to many of financing and by the COVID-19 and state of their to to the pandemic, in on issues and and to on issues such as to the began with the to Forecast Panelists The with has on the pharmacy leaders with as they the future. is in at the and state FPs were in that the trend of state government to by will it is that is not to or and are also under for as by the for and at the of Pharmacy leaders to with government leaders in their health by with establishing a pharmacy and for that access to and of Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where The past have a in of for organizations and have to of critical of FPs that or more of the used by health in the future will be through This could in a more for Pharmacy leaders in of and of to the of a pharmacy for possible. The survey in this of the Forecast that the most the of health will or more for of FPs this or most health and have with with The of of is some of the with and a process to outcomes over time. The for and is to some of in its that and the could to and health in more with as health take on more under organization or similar pharmacy leaders the use of to of In the to in the of health and the of and health In the Forecast of FPs it likely that and state for health systems. The has in for health a on the of the of our The of opinion of and for health may the likelihood of state and government actions that health systems. action that will health has The of the national and are likely to have an on the likelihood that will be specific action addressing the of and health systems. in the pharmacy are to to will the of any as survey the for to the That is the for in this The is about the likelihood that external could to the of FPs were in their about the of this with it likely and it The the that of will of the of that this is at likely to occur That more than of the FPs responded to is to about the of the in the pharmacy and are more than to services through that may external with health and A of survey that this may occur with external that to The of over the past has in the pharmacy Pharmacy leaders with respect to external and the of on of the be to the value health-system pharmacy is and the of strategic planning for pharmacy of the for to some or of a health-system pharmacy can be an for and with health-system government establishing a pharmacy policy that can be used to advocate at the state and national Pharmacy leaders the health-system policy and be to trends in the and environment. Pharmacy leaders with health-system leaders to for critical be possible. a of the and of the with system leaders pharmacy leaders to that are in with the organization and the likelihood of success. every of the pharmacy enterprise with respect to value to the and the that the or be by and in the future. The authors have of David of and of and James and Research Address correspondence to Dr. has been a for which pharmacists are suited to this on the of efforts and health systems. to of for the system in health toward through new new the and many pharmacists with the most have new to through a use of the staff and Forecast Panelists responded that it or that from will or pharmacists may a of from as This with a vision of that is a in a of health Some on through to staff and the of this to in such as and through and the in and are for not have the or of the The a to to and it can new to an organization’s efforts an on (or also not and on to the of to FPs may have been in this Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where a vision for must be with and we not this a for which is must the for from to and health-system vision must be with action and to and The of use must a and to and that will The underlying used by the and to has to use and new are and of the in has a of from The COVID-19 has to use a of new with or from Forecast survey as the COVID-19 of FPs it or likely that health pharmacy and will more the and of new of for The system a to and use a health and must on its to the for new to use the system to of and support for use The for is and FPs it likely issues be at the health-system and through in FPs it or likely that in of health the pharmacy will have an to support the and of its staff staff is to staff is not staff the staff in health some that from pharmacy efforts are from a on specific to staff support resources to many of in the from the COVID-19 pandemic, the need for resources has FPs were that in at of health a will be in an with it or likely This is consistent with the Pharmacy in which FPs it likely that pharmacy leaders take on by on and the health system to pharmacists have successfully taken on such pharmacists have the knowledge of the with as a which they can to in of in health systems. the system many and a of of a health it is for a to every of a or for a to be in an with to strategic for use and new by provocative on can be and into strategic with and a pharmacists are in health-system to and be to make contributions to the new and to and from the system to the and of used to new and or when is to be of the specific support resources in your health and specific actions for the of pharmacy members in the strategic planning Dr. on the AJHP Advisory Dr. has of A. of Pharmacy, PharmD, Pharmacy Address correspondence to Dr. DiPiro (jtdipiro@vcu.edu). The from to value in has been the pharmacy enterprise to on and of outcomes the of are toward use of for are with to in this of providing Forecast Panelists (FPs) that pharmacists will likely a in addressing the of services in and or and an for and access at the of the Forecast to the likely is it that the will by the in the geographic region where Forecast to the likely is it that the will by the in the geographic region where health have outcomes by pharmacists in to and patients and on the in is a to access of in many pharmacists practice and in access possible. The of pharmacists as part of will as the are and and for health FPs were to on the likelihood of positions to such as and health will likely to their services in and more pharmacists will practice in what will positions from in in new This will on the of in services or pharmacists of into their The on state by the of with health and to from will in of pharmacists in in workforce will be positions of to the of the pharmacy A of FPs that the pharmacy staff will An accurate and is to the and its are well in the of ASHP’s is of the vital pharmacy have in The pharmacy is to through of to their knowledge of and and access to the that are accurate and by the are critical in of of for members of the as likely or likely to occur by of FPs and of to and use of must be to is a within the hospital are for of a The to in are methods by which and recommendations can be made in the by FPs that pharmacists will for patients with with for is an for pharmacists to health The in a of services on development of a and state and and of FPs that and in health will will be critical as and are and to be in The and must that pharmacists to have the to practice in those providing with and for must be and to the develop a strategic to for pharmacy enterprise into and and where access to a can be for for pharmacists to of services patients with their in and as well as where access and to can be services to patients in the health system to that is that of pharmacists services are in the and that such is to the of services by pharmacists for patients in and in which is a for the of the in and health that pharmacists have the and to The authors have of A. for and The of of Pharmacy, and School of Pharmacy, and School of of Address correspondence Dr. Pharmacy workforce
No takes yet. Share an insight, caveat, or question.
DiPiro et al. (2021) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: